European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine

COVID-19 vaccine

The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s coronavirus vaccine.

The Advance Purchase Agreement will supply the European Union with these vaccine doses, upon approval and authorisation from regulators. The company is also in talks with other national governments and global organisations to make its vaccine candidate, CP-183528, available throughout the world.

Image caption:  Photo by Raysonho @ Open Grid Scheduler / Grid Engine

read more

Geen nieuws missen?
Volg de duizenden farma professionals die via e-mail lezen

Uw inschrijving is gelukt.